Status | Study |
Recruiting |
Study Name: International Registry on Cholangiocarcinoma Treatment Condition: Cholangiocarcinoma Date: 2013-08-07 Interventions: Drug: Doxorubicin Doxorubicina is loaded at the concentration of 50-75 mg/mq onto 2 ml of 70-150 µm |
Recruiting |
Study Name: VEGF Signaling Promotes Cell Growth and Metastasis in Intrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway Condition: Intrahepatic Cholangiocarcinoma Date: 2013-08-05 Interventions: Procedure: surgical treatment all the patients in the study must have been treated by the surgery at the |
Active, not recruiting |
Study Name: Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma Condition: Cholangiocarcinoma Date: 2013-07-17 Interventions: Radiation: Therasphere® in association with Gemcitabine and Cisplatin Therasphere® is a radioe |
Recruiting |
Study Name: A Phase I/II Study Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas Condition: Cholangiocarcinoma Date: 2013-05-15 Interventions: Drug: Amphinex and Gemcitabine |
Completed |
Study Name: A Study of Sunitinib in Patients With Advanced Cholangiocarcinoma Condition: Unresectable and Advanced Cholangiocarcinoma Date: 2012-10-22 Interventions: Drug: Sunitinib sunitinib dose :37.5mg/day Other Nam |
Completed |
Study Name: The Role of Gadoxetate (Eovist) Enhanced CT in Evaluating Cholangiocarcinoma Condition: Cholangiocarcinoma Date: 2012-08-13 Interventions: Radiation: CT scan Gadoxetate (Eovist) enhanced dual energy CT |
Completed |
Study Name: Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma Condition: Cholangiocarcinoma Date: 2012-01-31 Interventions: Drug: Everolimus 10 mg everolimus Other Name: RAD001 |
Completed |
Study Name: Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations Condition: Cholangiocarcinoma Date: 2010-09-20 Interventions: Drug: Gemcitabine 1,000 mg/m2 |
Terminated |
Study Name: Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma Condition: Cholangiocarcinoma Date: 2009-09-10 Interventions: Drug: WST11 WST11-mediated VTP will consist of the combination of a single IV administration of WST11 at |
Recruiting |
Study Name: Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol Condition: Cholangiocarcinoma Date: 2009-09-08 Interventions: Drug: RAD001 10mg/d Other Name: Everolimus |